166 related articles for article (PubMed ID: 28698805)
21. The lncRNA small nucleolar RNA host gene 5 regulates trophoblast cell proliferation, invasion, and migration via modulating miR-26a-5p/N-cadherin axis.
Yang Y; Xi L; Ma Y; Zhu X; Chen R; Luan L; Yan J; An R
J Cell Biochem; 2019 Mar; 120(3):3173-3184. PubMed ID: 30242892
[TBL] [Abstract][Full Text] [Related]
22. Long non-coding RNA and microRNA-675/let-7a mediates the protective effect of melatonin against early brain injury after subarachnoid hemorrhage via targeting TP53 and neural growth factor.
Yang S; Tang W; He Y; Wen L; Sun B; Li S
Cell Death Dis; 2018 Jan; 9(2):99. PubMed ID: 29367587
[TBL] [Abstract][Full Text] [Related]
23. miR-26a/HOXC9 Dysregulation Promotes Metastasis and Stem Cell-Like Phenotype of Gastric Cancer.
Peng X; Kang Q; Wan R; Wang Z
Cell Physiol Biochem; 2018; 49(4):1659-1676. PubMed ID: 30205370
[TBL] [Abstract][Full Text] [Related]
24. c-Myc Represses Tumor-Suppressive microRNAs, let-7a, miR-16 and miR-29b, and Induces Cyclin D2-Mediated Cell Proliferation in Ewing's Sarcoma Cell Line.
Kawano M; Tanaka K; Itonaga I; Iwasaki T; Tsumura H
PLoS One; 2015; 10(9):e0138560. PubMed ID: 26393798
[TBL] [Abstract][Full Text] [Related]
25. miR-26a regulates mouse hepatocyte proliferation via directly targeting the 3' untranslated region of CCND2 and CCNE2.
Zhou J; Ju WQ; Yuan XP; Zhu XF; Wang DP; He XS
Hepatobiliary Pancreat Dis Int; 2016 Feb; 15(1):65-72. PubMed ID: 26818545
[TBL] [Abstract][Full Text] [Related]
26. MicroRNA-26a inhibits proliferation by targeting high mobility group AT-hook 1 in breast cancer.
Zhao XX; Yuan QZ; Mu DP; Sun DW; Bo QA; Pan GZ; Li GQ; Cui T; Ding PP; You FP; Hao L; Wang MX; Zhang J
Int J Clin Exp Pathol; 2015; 8(1):368-73. PubMed ID: 25755724
[TBL] [Abstract][Full Text] [Related]
27. MicroRNA-26a regulates tumorigenic properties of EZH2 in human lung carcinoma cells.
Dang X; Ma A; Yang L; Hu H; Zhu B; Shang D; Chen T; Luo Y
Cancer Genet; 2012 Mar; 205(3):113-23. PubMed ID: 22469510
[TBL] [Abstract][Full Text] [Related]
28. [Periostin regulated by let-7/miR-98 family mediates the apoptosis and epithelial-mesenchymal transition of colon cancer].
Fu Q; Cheng J; Zhang JD; Zhang YL; Chen XB; Xie JG; Luo SX
Zhonghua Zhong Liu Za Zhi; 2019 Aug; 41(8):573-579. PubMed ID: 31434447
[No Abstract] [Full Text] [Related]
29. Prostate carcinoma cell-derived exosomal MicroRNA-26a modulates the metastasis and tumor growth of prostate carcinoma.
Wang X; Wang X; Zhu Z; Li W; Yu G; Jia Z; Wang X
Biomed Pharmacother; 2019 Sep; 117():109109. PubMed ID: 31229922
[TBL] [Abstract][Full Text] [Related]
30. Long non-coding RNA SNHG6 enhances cell proliferation, migration and invasion by regulating miR-26a-5p/MAPK6 in breast cancer.
Lv P; Qiu X; Gu Y; Yang X; Xu X; Yang Y
Biomed Pharmacother; 2019 Feb; 110():294-301. PubMed ID: 30522015
[TBL] [Abstract][Full Text] [Related]
31. The tumor suppressive miR-26a regulation of FBXO11 inhibits proliferation, migration and invasion of hepatocellular carcinoma cells.
Ma Y; Deng F; Li P; Chen G; Tao Y; Wang H
Biomed Pharmacother; 2018 May; 101():648-655. PubMed ID: 29518611
[TBL] [Abstract][Full Text] [Related]
32. Long non-coding RNA AK038897 aggravates cerebral ischemia/reperfusion injury via acting as a ceRNA for miR-26a-5p to target DAPK1.
Wei R; Zhang L; Hu W; Wu J; Zhang W
Exp Neurol; 2019 Apr; 314():100-110. PubMed ID: 30703362
[TBL] [Abstract][Full Text] [Related]
33. MiR-26a enhances the sensitivity of gastric cancer cells to cisplatin by targeting NRAS and E2F2.
Wen L; Cheng F; Zhou Y; Yin C
Saudi J Gastroenterol; 2015; 21(5):313-9. PubMed ID: 26458859
[TBL] [Abstract][Full Text] [Related]
34. LncRNA LOXL1-AS1/miR-let-7a-5p/EGFR-related pathway regulates the doxorubicin resistance of prostate cancer DU-145 cells.
Bai T; Liu Y; Li B
IUBMB Life; 2019 Oct; 71(10):1537-1551. PubMed ID: 31188543
[TBL] [Abstract][Full Text] [Related]
35. MicroRNA-26a inhibits TGF-β-induced extracellular matrix protein expression in podocytes by targeting CTGF and is downregulated in diabetic nephropathy.
Koga K; Yokoi H; Mori K; Kasahara M; Kuwabara T; Imamaki H; Ishii A; Mori KP; Kato Y; Ohno S; Toda N; Saleem MA; Sugawara A; Nakao K; Yanagita M; Mukoyama M
Diabetologia; 2015 Sep; 58(9):2169-80. PubMed ID: 26063197
[TBL] [Abstract][Full Text] [Related]
36. Long non-coding RNA SNHG5 sponges miR-26a to promote the tumorigenesis of osteosarcoma by targeting ROCK1.
Wang Z; Wang Z; Liu J; Yang H
Biomed Pharmacother; 2018 Nov; 107():598-605. PubMed ID: 30114643
[TBL] [Abstract][Full Text] [Related]
37. Knockdown of growth-arrest specific transcript 5 restores oxidized low-density lipoprotein-induced impaired autophagy flux via upregulating miR-26a in human endothelial cells.
Liang W; Fan T; Liu L; Zhang L
Eur J Pharmacol; 2019 Jan; 843():154-161. PubMed ID: 30468731
[TBL] [Abstract][Full Text] [Related]
38. MicroRNA-26a targets MAPK6 to inhibit smooth muscle cell proliferation and vein graft neointimal hyperplasia.
Tan J; Yang L; Liu C; Yan Z
Sci Rep; 2017 Apr; 7():46602. PubMed ID: 28429763
[TBL] [Abstract][Full Text] [Related]
39. Regulation of the collagen cross-linking enzymes LOXL2 and PLOD2 by tumor-suppressive microRNA-26a/b in renal cell carcinoma.
Kurozumi A; Kato M; Goto Y; Matsushita R; Nishikawa R; Okato A; Fukumoto I; Ichikawa T; Seki N
Int J Oncol; 2016 May; 48(5):1837-46. PubMed ID: 26983694
[TBL] [Abstract][Full Text] [Related]
40. Metformin alters the expression profiles of microRNAs in human pancreatic cancer cells.
Li W; Yuan Y; Huang L; Qiao M; Zhang Y
Diabetes Res Clin Pract; 2012 May; 96(2):187-95. PubMed ID: 22245693
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
